Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. FBLG
FBLG logo

FBLG

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

FBLG News

FibroBiologics Regains Nasdaq Compliance with Key Requirements Met

9h agoseekingalpha

FibroBiologics Unveils Data on Reversing Immune Decline

Apr 10 2026Newsfilter

FibroBiologics Achieves Key Milestone with CYWC628 Drug Batch Manufacturing

Apr 01 2026NASDAQ.COM

FibroBiologics Prices Public Offering at $1.32 per Share

Apr 01 2026Newsfilter

FibroBiologics Prices Public Offering at $1.32 per Share

Apr 01 2026Yahoo Finance

FibroBiologics Files for $5M Public Offering Amid Reverse Split

Mar 30 2026seekingalpha

FibroBiologics Approves 1-for-20 Reverse Stock Split

Mar 25 2026seekingalpha

FibroBiologics Approves 1-for-20 Reverse Stock Split

Mar 25 2026Newsfilter

FIBROBIOLOGICS INC - BOARD AUTHORIZES 1-FOR-20 REVERSE STOCK SPLIT

Mar 25 2026moomoo

Avaí Bio Initiates Production of α-Klotho Cell Bank

Mar 18 2026Globenewswire

FibroBiologics Completes Onboarding for DFU Clinical Trial

Mar 05 2026Newsfilter

Avaí Bio Advances Cell Therapy Production Milestone

Mar 03 2026PRnewswire

Avaí Bio Advances α-Klotho Cell Production Milestone

Mar 03 2026Newsfilter

FibroBiologics Shares Surge 22% After New Patent Grant for Osteoporosis Treatment

Mar 02 2026NASDAQ.COM

FibroBiologics Secures New Patent for Osteoporosis Treatment

Mar 02 2026Newsfilter

FibroBiologics Reports Increased Losses for 2025 Fiscal Year

Feb 24 2026seekingalpha